Skip to main content
logo
Kyung Dong Pharmaceutical Co., Ltd. (KOSDAQ:011040)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,845.00
+95.00 (2.00%)
At close: Jul 31, 2026

Kyung Dong Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
11,6338,5295,470-20,70812,16112,672
Depreciation & Amortization
3,8323,6785,4205,8496,7047,011
Loss (Gain) From Sale of Assets
-2,280-2,094-92.39-61.03142.27-73.22
Asset Writedown & Restructuring Costs
--197.41---
Loss (Gain) From Sale of Investments
-1,698748.83-1,765-2,1491,709-786.97
Loss (Gain) on Equity Investments
-863.6666.38-503.27-3,083-11,387155.57
Provision & Write-off of Bad Debts
---1,57764.766
Other Operating Activities
3,0562,476-6,917-236.454,218-2,090
Change in Accounts Receivable
-1,9952,250-2,8164,146-3,855-3,561
Change in Inventory
5,334172.68-7,837-4,494-2,619-636.73
Change in Accounts Payable
-1,840-344.59123.61-776.13-92.641,873
Change in Other Net Operating Assets
1,9121,452646.219,904-8,119-2,207
Operating Cash Flow
17,09016,934-8,074-31.94-1,07512,422
Operating Cash Flow Growth
32.78%-----27.42%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-17,143-18,394-7,618-6,290-10,574-3,926
Sale of Property, Plant & Equipment
2,4952,518993.5344.32126.36222.18
Sale (Purchase) of Intangibles
-1,622-1,968-3,792-1,677161.82-811.28
Investment in Securities
11,80512,64710,51322,985-3,74912,145
Other Investing Activities
3,2843,7552,1683,3011,4492,786
Investing Cash Flow
-1,182-1,1432,26418,664-12,58510,713

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-151,609162,522110,59468,182-
Long-Term Debt Issued
-18,400----
Total Debt Issued
127,429170,009162,522110,59468,182-
Short-Term Debt Repaid
--160,250-138,897-119,663-44,251-481.93
Long-Term Debt Repaid
--79.52-148.88-573.83-1,595-1,534
Total Debt Repaid
-135,295-160,330-139,046-120,237-45,846-2,016
Net Debt Issued (Repaid)
-7,8669,68023,476-9,64322,336-2,016
Repurchase of Common Stock
---1,280--750.51-5,517
Dividends Paid
-8,083-8,083-10,854-10,854-10,894-13,834
Other Financing Activities
-1,274-1,399-1,729-921.28-304.11-106.26
Financing Cash Flow
-17,222198.629,613-21,41810,388-21,474

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
75.2949.97186.5811.7517.78153.47
Miscellaneous Cash Flow Adjustments
-0-0--0-
Net Cash Flow
-1,23916,0403,990-2,774-3,2541,815

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-52.77-1,460-15,692-6,322-11,6498,496
Free Cash Flow Growth
------
Free Cash Flow Margin
-0.03%-0.74%-8.09%-3.89%-6.38%4.78%
Free Cash Flow Per Share
-1.93-53.82-582.38-232.98-428.12308.70
Levered Free Cash Flow
-5,298-8,976-22,117510.19-2,7736,388
Unlevered Free Cash Flow
-4,179-7,867-20,7671,508-2,2316,429

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,2741,3991,769921.28244.116.26
Cash Income Tax Paid
858.19387.84,7772,7965,6928,698
Change in Working Capital
3,4123,530-9,88318,780-14,686-4,532